Get the Stockscreener App
3.755
1.76%
0.065
Briacell Therapeutics Corp stock is traded at $3.755, with a volume of 30,181.
It is up +1.76% in the last 24 hours and up +4.89% over the past month.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$3.69
Open:
$3.71
24h Volume:
30,181
Relative Volume:
0.52
Market Cap:
$32.67M
Revenue:
Net Income/Loss:
$-30.98M
P/E Ratio:
-0.3075
EPS:
-12.2116
Net Cash Flow:
$-31.84M
1W Performance:
-4.21%
1M Performance:
+4.89%
6M Performance:
-18.72%
1Y Performance:
-67.96%
1-Day Range:
$3.70
$3.8499
1-Week Range:
$3.67
$4.00
52-Week Range:
$2.60
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.755 | 32.67M | 0 | -30.98M | -31.84M | -12.21 |
VRTX
Vertex Pharmaceuticals Inc
|
508.71 | 128.94B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
238.63 | 95.27B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
799.98 | 82.36B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
855.28 | 53.79B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.53 | 42.37B | 5.76B | 514.49M | 1.10B | 4.4813 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
BriaCell Therapeutics Corp. - Baystreet.ca
BriaCell Therapeutics Warrant (BCTXL) Rises 2.18% to $1.17 as It Pushes Toward Range ResistanceVolatility Smile - https://www.dars.gov.et/
BriaCell Therapeutics Warrant (BCTXL) Rises 2.18% to $1.17 as It Pushes Toward Range ResistanceOBV Breakout - https://www.siam.in/
Scienture Holdings, Inc. (SCNX) Stock Price & News - Syfe
Kairos Pharma, Ltd. (KAPA) Stock Price & News - Syfe
BriaCell Therapeutics Warrant (BCTXL) Retreats 11.3% as Traders Test Support Near $0.97Strangle Setup - dars.gov.et
Stocks In Play - baystreet.ca
Price to earnings forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
(BCT) Market Dynamics and Trading Signals (BCT:CA) - Stock Traders Daily
Price to book forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer - marketscreener.com
Equity in earnings of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Book value per share of BriaCell Therapeutics Corp – HAM:8BT - TradingView
BriaCell Therapeutics Corp. (TSX:BCT) Advances as Immunotherapy Pipeline Progress and Clinical Momentum Drive Investor Optimism - kalkine.ca
Net income before discontinued operations of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Free float of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Nature Medicine features a BriaCell trial among 11 shaping medicine in 2026 - Stock Titan
BriaCell Therapeutics (BCTX) Edges Higher as Shares Hold Above Key Support at $3.42Volume Breakout Ideas - careplusvn.com
BriaCell Therapeutics (BCTX) Edges Higher as Shares Hold Above Key Support at $3.42Outside Reversal - dars.gov.et
BriaCell Therapeutics (BCTX) Edges Higher as Shares Hold Above Key Support at $3.42Bull Flag - dars.gov.et
BriaCell Therapeutics (BCTX) Edges Higher as Shares Hold Above Key Support at $3.42Volatility Breakout Picks - dars.gov.et
BriaCell Therapeutics (BCTX) Edges Higher as Shares Hold Above Key Support at $3.42Hull Moving Average - https://www.dars.gov.et/
(BCT) Strategic Equity Report (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics Corp (BCTXW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BriaCell Therapeutics Corp (BCTXW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Briacell Therapeutics Corp (BCTX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Briacell Therapeutics Corp (BCTX) Peer Comparison – Compare with Others - Value Research
Certain Warrants of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 2-SEP-2026. - marketscreener.com
Certain Options of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 2-SEP-2026. - marketscreener.com
BriaCell's Cell-Based ‘Melanoma’ Enters the Skin Cancer Vaccine Conversation - Investing News Network
BriaCell Therapeutics Stock Faces Renewed Pressure as Biotech Volatility Tests Investor Conviction - kalkine.ca
BriaCell Therapeutics Corp. (TSX:BCT) Falls 4.24% as Clinical-Stage Risk and Volatility Pressure Sentiment - kalkine.ca
BriaCell Therapeutics Corp (BCTXW) Peer Comparison – Compare with Others - Value Research
Ensysce Biosciences, Inc. (ENSC) Stock Price & News - Syfe
Bullfrog AI Holdings, Inc. (BFRG) Stock Price & News - Syfe
RNAZ Stock Price, Quote & News - Syfe
Briacell Therapeutics Corp (BCTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Valion Bio, Inc. (VBIO) Stock Price & News - Syfe
BriaCell Therapeutics Stock Falls Sharply: Can TSX:BCT Stabilize After Renewed Biotech Selling Pressure? - kalkine.ca
BriaCell Therapeutics Warrant (BCTXL) Climbs 2.79% to $0.96 as Biotech Warrants Draw Fresh AttentionVolume Breakout Ideas - dars.gov.et
BriaCell Therapeutics Stock Falls 6.41%: Why TSX:BCT Is in Focus as Breast and Prostate Cancer Pipeline Advances - kalkine.ca
BriaCell Therapeutics Corp. (TSX:BCT) Gains Momentum as Immunotherapy Pipeline Progress Supports Investor Optimism - kalkine.ca
BriaCell Therapeutics (TSX:BCT) Advances 6.6% on a Run of Pipeline Milestones - kalkine.ca
BriaCell in Focus: TSX: BCT Investors Watch Major Immunotherapy Milestones Ahead of Clinical Data - kalkine.ca
BriaCell Therapeutics Stock: When the Share Price Becomes a Mood Ring - kalkine.ca
BriaCell stock choppy on melanoma vaccine milestone - Investing.com
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™ - Yahoo Finance
BriaCell (BCTX) Results Review: EPS Exceeds Its Estimate for the Current Session; Market Reaction - dars.gov.et
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):